• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤衍生的细胞外囊泡调节骨髓免疫微环境。

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment.

机构信息

Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.

Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

出版信息

Front Immunol. 2022 Jul 7;13:909880. doi: 10.3389/fimmu.2022.909880. eCollection 2022.

DOI:10.3389/fimmu.2022.909880
PMID:35874665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9302002/
Abstract

Multiple myeloma (MM), the third most frequent hematological cancer worldwide, is characterized by the proliferation of neoplastic plasma cells in the bone marrow (BM). One of the hallmarks of MM is a permissive BM microenvironment. Increasing evidence suggests that cell-to-cell communication between myeloma and immune cells tumor cell-derived extracellular vesicles (EV) plays a key role in the pathogenesis of MM. Hence, we aimed to explore BM immune alterations induced by MM-derived EV. For this, we inoculated immunocompetent BALB/cByJ mice with a myeloma cell line, MOPC315.BM, inducing a MM phenotype. Upon tumor establishment, characterization of the BM microenvironment revealed the expression of both activation and suppressive markers by lymphocytes, such as granzyme B and PD-1, respectively. In addition, conditioning of the animals with MOPC315.BM-derived EV, before transplantation of the MOPC315.BM tumor cells, did not anticipate the disease phenotype. However, it induced features of suppression in the BM milieu, such as an increase in PD-1 expression by CD4+ T cells. Overall, our findings reveal the involvement of MOPC315.BM-derived EV protein content as promoters of immune niche remodeling, strengthening the importance of assessing the mechanisms by which MM may impact the immune microenvironment.

摘要

多发性骨髓瘤(MM)是全球第三大常见的血液系统恶性肿瘤,其特征是骨髓(BM)中恶性浆细胞的增殖。MM 的一个标志是允许的 BM 微环境。越来越多的证据表明,骨髓瘤和免疫细胞之间的细胞间通讯——肿瘤细胞衍生的细胞外囊泡(EV)——在 MM 的发病机制中起着关键作用。因此,我们旨在探索 MM 衍生 EV 诱导的 BM 免疫改变。为此,我们用骨髓瘤细胞系 MOPC315.BM 接种免疫功能正常的 BALB/cByJ 小鼠,诱导 MM 表型。在肿瘤建立后,对 BM 微环境的特征分析显示,淋巴细胞表达了激活和抑制标志物,分别为颗粒酶 B 和 PD-1。此外,在移植 MOPC315.BM 肿瘤细胞之前,用 MOPC315.BM 衍生的 EV 对动物进行预处理并没有预料到疾病表型。然而,它诱导了 BM 环境中的抑制特征,例如 CD4+T 细胞中 PD-1 表达的增加。总的来说,我们的研究结果揭示了 MOPC315.BM 衍生 EV 蛋白含量作为免疫生态位重塑的促进剂的参与,这加强了评估 MM 可能影响免疫微环境的机制的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/cad6c8a79a82/fimmu-13-909880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/225721d29c63/fimmu-13-909880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/ad354e1d2434/fimmu-13-909880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/77a839c70ebb/fimmu-13-909880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/cad6c8a79a82/fimmu-13-909880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/225721d29c63/fimmu-13-909880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/ad354e1d2434/fimmu-13-909880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/77a839c70ebb/fimmu-13-909880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835d/9302002/cad6c8a79a82/fimmu-13-909880-g004.jpg

相似文献

1
Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment.多发性骨髓瘤衍生的细胞外囊泡调节骨髓免疫微环境。
Front Immunol. 2022 Jul 7;13:909880. doi: 10.3389/fimmu.2022.909880. eCollection 2022.
2
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.骨髓微环境中的细胞外囊泡相互作用:对多发性骨髓瘤的影响
Oncotarget. 2016 Jun 21;7(25):38927-38945. doi: 10.18632/oncotarget.7792.
3
A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease.一种新型多发性骨髓瘤(MOPC315.BM)小鼠模型,可实现溶骨性疾病的非侵入性时空检测。
PLoS One. 2012;7(12):e51892. doi: 10.1371/journal.pone.0051892. Epub 2012 Dec 20.
4
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.新抗原疫苗诱导的 CD4 T 细胞通过激活针对非疫苗、肿瘤相关抗原的 CD8 T 细胞,在多发性骨髓瘤的小鼠模型中赋予保护性免疫。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003572.
5
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.来那度胺增强免疫检查点阻断诱导的多发性骨髓瘤免疫反应。
Clin Cancer Res. 2015 Oct 15;21(20):4607-18. doi: 10.1158/1078-0432.CCR-15-0200. Epub 2015 May 15.
6
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.破骨细胞在多发性骨髓瘤中的免疫抑制作用:程序性细胞死亡配体 1 的作用。
Front Immunol. 2018 Aug 10;9:1822. doi: 10.3389/fimmu.2018.01822. eCollection 2018.
7
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way.细胞外囊泡以 NOTCH 依赖的方式介导多发性骨髓瘤与骨髓微环境之间的通讯。
Haematologica. 2022 Sep 1;107(9):2183-2194. doi: 10.3324/haematol.2021.279716.
8
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.冒烟型骨髓瘤和活动性多发性骨髓瘤患者骨髓免疫微环境中 PD-L1/PD-1 的表达模式。
Front Immunol. 2021 Jan 8;11:613007. doi: 10.3389/fimmu.2020.613007. eCollection 2020.
9
Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination.细胞外囊泡促进多发性骨髓瘤的转移扩散。
Int J Mol Sci. 2019 Jul 1;20(13):3236. doi: 10.3390/ijms20133236.
10
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status.免疫功能障碍影响多发性骨髓瘤骨髓 Vγ9Vδ2 T 细胞:免疫检查点和疾病状态的作用。
Front Immunol. 2022 Dec 20;13:1073227. doi: 10.3389/fimmu.2022.1073227. eCollection 2022.

引用本文的文献

1
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1.多发性骨髓瘤患者骨髓来源的细胞外囊泡通过HLA-G、PD-1和PD-L1促进适应性免疫功能障碍。
Front Immunol. 2025 Aug 28;16:1640168. doi: 10.3389/fimmu.2025.1640168. eCollection 2025.
2
Exosomal miRNA expression profiling in patients with imatinib resistant Chronic myeloid leukemia: A pilot study.伊马替尼耐药慢性髓性白血病患者的外泌体miRNA表达谱:一项初步研究。
PLoS One. 2025 Aug 29;20(8):e0331479. doi: 10.1371/journal.pone.0331479. eCollection 2025.
3
USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis.

本文引用的文献

1
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study.患者来源的细胞外囊泡蛋白作为多发性骨髓瘤的新型生物标志物——一项真实世界研究
Front Oncol. 2022 Jun 21;12:860849. doi: 10.3389/fonc.2022.860849. eCollection 2022.
2
CD3CD4CD8 (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.CD3CD4CD8(双阴性)T 细胞在炎症、免疫紊乱和癌症中的作用。
Front Immunol. 2022 Feb 10;13:816005. doi: 10.3389/fimmu.2022.816005. eCollection 2022.
3
Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells.
USP5通过激活STAT2-PFKFB4介导的糖酵解来激发多发性骨髓瘤中的免疫抑制微环境。
Cancer Immunol Immunother. 2025 Apr 24;74(6):180. doi: 10.1007/s00262-025-04031-1.
4
The negative effects of extracellular vesicles in the immune system.细胞外囊泡在免疫系统中的负面效应。
Front Immunol. 2024 Sep 20;15:1410273. doi: 10.3389/fimmu.2024.1410273. eCollection 2024.
5
Multiple myeloma: signaling pathways and targeted therapy.多发性骨髓瘤:信号通路与靶向治疗。
Mol Biomed. 2024 Jul 4;5(1):25. doi: 10.1186/s43556-024-00188-w.
6
Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation.单核细胞摄取多发性骨髓瘤来源的细胞外囊泡可刺激白细胞介素-6和基质金属蛋白酶-9的分泌,并促进癌细胞迁移和增殖。
Cancers (Basel). 2024 Feb 29;16(5):1011. doi: 10.3390/cancers16051011.
7
Exosomes-Promising Carriers for Regulatory Therapy in Oncology.外泌体——肿瘤调节治疗中颇具前景的载体
Cancers (Basel). 2024 Feb 25;16(5):923. doi: 10.3390/cancers16050923.
8
Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment.血液系统恶性肿瘤中的细胞外囊泡:重塑肿瘤微环境的细胞外囊泡证据
Front Immunol. 2023 Sep 26;14:1265969. doi: 10.3389/fimmu.2023.1265969. eCollection 2023.
9
Non-Classical Intercellular Communications: Basic Mechanisms and Roles in Biology and Medicine.非经典细胞间通讯:生物学和医学中的基本机制和作用。
Int J Mol Sci. 2023 Mar 29;24(7):6455. doi: 10.3390/ijms24076455.
10
Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells.用于研究原代骨髓脂肪细胞与骨髓瘤细胞之间关系的三种细胞培养系统的开发与特性分析。
Front Oncol. 2023 Jan 11;12:912834. doi: 10.3389/fonc.2022.912834. eCollection 2022.
多发性骨髓瘤来源的细胞外囊泡通过作用于造血干细胞和祖细胞损害正常造血。
Front Med (Lausanne). 2021 Dec 16;8:793040. doi: 10.3389/fmed.2021.793040. eCollection 2021.
4
Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell Lymphoma Subtyping.用于弥漫性大 B 细胞淋巴瘤分型的细胞外囊泡的蛋白质组学全景。
Int J Mol Sci. 2021 Oct 12;22(20):11004. doi: 10.3390/ijms222011004.
5
mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation.mTOR抑制剂通过IKZF3和Blimp-1介导的BCL-2上调使多发性骨髓瘤细胞对维奈托克敏感。
Haematologica. 2021 Nov 1;106(11):3008-3013. doi: 10.3324/haematol.2021.278506.
6
Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.核糖体蛋白作为微泡中的独特“乘客”:骨髓瘤和间充质干细胞通讯的新语义。
Transl Res. 2021 Oct;236:117-132. doi: 10.1016/j.trsl.2021.04.002. Epub 2021 Apr 20.
7
Boosting Immunity against Multiple Myeloma.增强对多发性骨髓瘤的免疫力。
Cancers (Basel). 2021 Mar 11;13(6):1221. doi: 10.3390/cancers13061221.
8
Function of γδ T cells in tumor immunology and their application to cancer therapy.γδ T 细胞在肿瘤免疫学中的功能及其在癌症治疗中的应用。
Exp Mol Med. 2021 Mar;53(3):318-327. doi: 10.1038/s12276-021-00576-0. Epub 2021 Mar 12.
9
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?多发性骨髓瘤中的免疫微环境:朋友还是敌人?
Cancers (Basel). 2021 Feb 5;13(4):625. doi: 10.3390/cancers13040625.
10
Employing Flow Cytometry to Extracellular Vesicles Sample Microvolume Analysis and Quality Control.运用流式细胞术进行细胞外囊泡样本微量分析及质量控制。
Front Cell Dev Biol. 2020 Oct 30;8:593750. doi: 10.3389/fcell.2020.593750. eCollection 2020.